Actual enrollment decreased by 1 participants
Before: 501 participants (actual). After: 500 participants (actual).
Study sponsor: Revolution Medicines, Inc. · RVMD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 501 participants (actual). After: 500 participants (actual).
Before: Estimated. After: Actual.
Before: 460 participants (planned). After: 501 participants (actual).
Before: Recruiting. After: Active not recruiting.